Rare diseases
Investigational molecules
Locations
Back to France785 clinical trials in Chambery, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
FranceStudy of tucatinib, pertuzumab and trastuzumab combination for patients with HER2-positive metastatic breast cancer who have brain metastases after local therapy
FranceComparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety
FranceStudy of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache
FranceStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
FranceStudy on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
FranceStudy on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease
FranceStudy of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer
FranceStudy Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation
FranceStudy on Idiopathic Pulmonary Fibrosis: Evaluating Pirfenidone and Nintedanib for Patients with Progressive Disease
FranceStudy on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients
FranceLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma and various lymphomas, evaluating novel therapeutic combinations and treatment strategies.
Advanced trials exploring combinations of immunotherapy and targeted treatments for blood cancers.
Studies examining innovative treatments for non-small cell lung cancer, particularly focusing on immunotherapy approaches.
Emphasis on improving treatment outcomes through targeted and combination therapies.
Research on pneumococcal vaccines and preventive treatments, including studies in specialized patient populations.
Focus on vaccine effectiveness during acute illness conditions.
Clinical trials examining treatments for hormone-sensitive breast cancer, including targeted therapies and hormone treatment optimization.
Investigation of personalized treatment approaches based on molecular markers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
